Premier Bone Health
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
Other Combinations
Product Type
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Vitamin K2 | — | — |
| Calcium | — | — |
| Aquamin F Mineralized Red Algae | — | — |
| Cetyl Fatty Acids | — | — |
| Cetyl Myristate | — | — |
| Cetyl Myristoleate | — | — |
| organic Chlorella | — | — |
| organic Prickly Pear | — | — |
| Reishi | — | — |
| Tocotrienols | — | — |
| organic Parsley | — | — |
| organic Turmeric | — | — |
| organic Alfalfa | — | — |
| Indian Frankincense (resin) extract | — | — |
| Plant-Source Capsule | — | — |
| Silicon Dioxide | — | — |
Label Claims — Verification
❓
Nutrient
❓
All Other
❓
Structure/Function
All Other (100% of products)
Structure/Function (84% of products)
Nutrient (73% of products)
Target Groups
Adults and children 4 or more years of age
Product Details
DSLD Entry Date
2022-06-16
Product Type
Other Combinations
Form
Capsule
Brand
Premier Research Labs
DSLD ID
269205
Data Updated
2026-04-10
Research Evidence
332
Research Sources
59
Avg Quality Score
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
A
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Compare Similar Products
Vitamin D Synergy with Vitamin K1
Designs for Health
100
Vitamin D Synergy with Vitamin K1
Designs for Health
100
Natural Vitamin K2 45 mcg
Doctor's Best
100
K 100 mcg
Thompson
100
Vitamin K2 300 mcg MK-7
Innerzyme
100